Send mail to Author

Randomized trial of the efficacy and safety of Berotralstat (BCX7353) as an oral prophylactic therapy for hereditary angioedema: results of APeX-2 ihrough 48 weeks (Part 2) (Article)

Please indicate your contact information and select, which author you want to contact.



 
  ______    ______   __   __     ___      ____      ______  
 /_____//  /_   _//  \ \\/ //   / _ \\   |  _ \\   /_   _// 
 `____ `    -| ||-    \   //   | / \ ||  | |_| ||   -| ||-  
 /___//     _| ||_    / . \\   | \_/ ||  | .  //    _| ||_  
 `__ `     /_____//  /_//\_\\   \___//   |_|\_\\   /_____// 
 /_//      `-----`   `-`  --`   `---`    `-` --`   `-----`  
 `-`                                                        
 


Back to frontdoor view